Join Our Discussion
The Myelin Repair Foundation, Ewing Marion Kauffman Foundation, Pioneer Portfolio of the Robert Wood Johnson Foundation, and the Scott Cook & Signe Ostby Foundation invite you to participate in an interactive webinar to discuss a new drug development model employed by the Myelin Repair Foundation with the potential to cut years from the drug development timeline, saving lives and money.
Thursday, March 25, 2010
1 p.m. EDT, Noon CDT, 10 a.m. PDT
Developing Cures with Less Time & Capital:
A New Research Model to Accelerate Drug Development
WEBINAR LINK:
https://kauffman.webex.com
CALL-IN NUMBER:
719-325-2331 or toll-free, 888-430-8690
Confirmation Code: 2798343
As the nation deals with spiraling drug costs and an urgent need for new treatments, the Myelin Repair Foundation has pioneered a holistic approach to multiple sclerosis drug development that bridges the gap between the promising discoveries made in academic laboratories and big-pharmaceutical drug research and development. The approach shows early promise in cutting development costs and shaving years off of the time it takes to move a drug from basic science to patient therapy.
The Myelin Repair Foundation’s approach will not only benefit the millions living with MS but also provides a new source of high-quality drug targets for the dwindling biopharma pipelines.
Learn why the Ewing Marion Kauffman Foundation, Pioneer Portfolio of the Robert Wood Johnson Foundation, and the Scott Cook & Signe Ostby Foundation are investing in MRF’s unique approach, its potential to accelerate the drug development process, and why this should call attention to the demand for a new research paradigm.
The session will include an interactive Q&A portion where participants can direct questions to participating panelists.
WHO:
Scott Johnson, President and Founder, Myelin Repair Foundation
Lesa Mitchell, Vice President, Advancing Innovation, Kauffman Foundation
Nancy Barrand, Special Advisor for Program Development, Robert Wood Johnson Foundation
Scott Cook, Co-founder of the Scott Cook & Signe Ostby Foundation and Co-founder of Intuit Inc.
Contact Information:
Martin Maisonpierre
martin.maisonpierre@edelman.com
Office: (212) 704-8111
Please follow the online conversation about the call on Twitter by following the hash tag #myelincures.
